Zydus Lifesciences Q4 Results Live : profit rise by 298.62% YOY

Zydus Lifesciences Q4 Results Live : Zydus Lifesciences declared their Q4 results on 17 May, 2024. The topline increased by 18.56% & the profit increased by 298.62% YoY. As compared to the previous quarter the revenue grew by 22.83% and the profit increased by 49.73%.

The Selling, general & administrative expenses rose by 2.41% q-o-q & increased by 15.62% Y-o-Y.

The operating income was up by 60.08% q-o-q & increased by 642.24% Y-o-Y.

The EPS is ₹11.66 for Q4 which increased by 61.53% Y-o-Y.

Zydus Lifesciences has delivered 4.21% return in the last 1 week, 59.69% return in last 6 months and 46.4% YTD return.

Currently the Zydus Lifesciences has a market cap of ₹101529 Cr and 52wk high/low of ₹1033 & ₹484.95 respectively.

As of 18 May, 2024 out of 26 analysts covering the company, 2 analysts have given Strong Sell rating, 4 analysts have given Sell rating, 9 analysts have given Hold rating, 6 analysts have given Buy rating &5 analysts have given Strong Buy rating.

The consensus recommendation as on 18 May, 2024 was to Hold.